PNC Financial Services Group
CSTL icon

PNC Financial Services Group’s Castle Biosciences CSTL Stock Holding History

PNC Financial Services Group’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.74K Sell
157
-6
-4% -$134 ﹤0.01% 4492
2026
Q1 		$4K Sell
163
-383
-70% -$12.5K ﹤0.01% 4365
2025
Q4 		$21.2K Buy
546
+431
+375% +$13.9K ﹤0.01% 3625
2025
Q3 		$2.62K Buy
115
+5
+5% +$102 ﹤0.01% 4425
2025
Q2 		$2.25K Sell
110
-10
-8% -$185 ﹤0.01% 4379
2025
Q1 		$2.4K Buy
+120
New +$2.97K ﹤0.01% 4293
2024
Q2 		– Sell
-38
Closed -$842 – 4783
2024
Q1 		$842 Hold
38
– – ﹤0.01% 4403
2023
Q4 		$820 Sell
38
-2,226
-98% -$39.2K ﹤0.01% 4345
2023
Q3 		$38.2K Sell
2,264
-337
-13% -$5.89K ﹤0.01% 3093
2023
Q2 		$35.7K Buy
2,601
+5
+0.2% +$101 ﹤0.01% 3250
2023
Q1 		$59K Sell
2,596
-154
-6% -$3.76K ﹤0.01% 2888
2022
Q4 		$64.7K Sell
2,750
-985
-26% -$22.8K ﹤0.01% 2823
2022
Q3 		$97K Buy
3,735
+41
+1% +$1.15K ﹤0.01% 2549
2022
Q2 		$81K Sell
3,694
-51
-1% -$1.19K ﹤0.01% 2704
2022
Q1 		$168K Buy
3,745
+1,290
+53% +$53.3K ﹤0.01% 2380
2021
Q4 		$105K Buy
2,455
+960
+64% +$50.2K ﹤0.01% 2651
2021
Q3 		$99K Buy
1,495
+147
+11% +$10.3K ﹤0.01% 2657
2021
Q2 		$99K Sell
1,348
-53
-4% -$3.5K ﹤0.01% 2664
2021
Q1 		$96K Buy
1,401
+51
+4% +$3.83K ﹤0.01% 2597
2020
Q4 		$91K Buy
+1,350
New +$73.2K ﹤0.01% 2549

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PNC Financial Services Group's CSTL Position: Q2 2026 in Review

PNC Financial Services Group reduced its Castle Biosciences (CSTL) stake by 3.7% in Q2 2026, selling an estimated $134 and leaving 157 shares worth $3.74K. The position accounts for ﹤0.01% of the portfolio, ranked #4492.

PNC Financial Services Group first reported a position in CSTL in Q4 2020 and has held it in 20 quarters since. The position peaked at $168K in Q1 2022. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • PNC Financial Services Group held 157 shares of Castle Biosciences worth $3.74K as of Q2 2026.
  • PNC Financial Services Group sold 6 Castle Biosciences shares in Q2 2026, an estimated $134.
  • Castle Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4492 holding.
  • PNC Financial Services Group first reported a position in Castle Biosciences in Q4 2020 and has held it in 20 quarters since.
  • PNC Financial Services Group's Castle Biosciences position peaked at $168K in Q1 2022.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.